EPISODE · Dec 19, 2012 · 4 MIN
Mergers and Acquisitions in Consumer Health
from Euromonitor Podcasts · host Euromonitor International
Large pharmaceutical companies such as Pfizer and Sanofi are investing in the supplement category, a potential growth opportunity for pharmaceuticals. This category, once ignored by pharmaceutical companies, is almost as large as over-the-counter medication in terms of global retail sales. Chris Schmidt, Consumer Health Company Analyst at Euromonitor, cites several key areas of M&A activity in consumer health.Lots of brands claim to be number one… but can they prove it?At Euromonitor International, we help brands build trust through evidence-based research. Our claim validation service ensures your marketing messages are backed by real data. Stand out in a crowded market. Visit euromonitor.com/claims to learn more.
Embed this episode
What this episode covers
Large pharmaceutical companies such as Pfizer and Sanofi are investing in the supplement category, a potential growth opportunity for pharmaceuticals. This category, once ignored by pharmaceutical companies, is almost as large as over-the-counter medication in terms of global retail sales. Chris Schmidt, Consumer Health Company Analyst at Euromonitor, cites several key areas of M&A activity in consumer health. Lots of brands claim to be number one… but can they prove it? At Euromonitor In...
NOW PLAYING
Mergers and Acquisitions in Consumer Health
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.